Abstract 1138: Breast cancer-derived mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor signaling
Shan Cheng(Capital Medical University), Junqi He(Qingdao University), Ying Xiong(Capital Medical University), Licui Sun(Capital Medical University), Yang Li(Foundation for the National Institutes of Health), Duiping Feng(Shanxi Medical University), Ying Yang(Guiyang Medical University), Yunying Zhou(Shandong University), Wen G. Jiang(Shandong Center for Disease Control and Prevention), Longyan Yang(Beijing Luhe Hospital Affiliated to Capital Medical University)
Cited by 0
Related Papers
VEGF-B inhibits apoptosis via VEGFR-1–mediated suppression of the expression of BH3-only protein genes in mice and rats
|Journal of Clinical Investigation|2008|194
Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development
|Journal of Medicinal Chemistry|2014|151
Proteomic Analysis of β1-Adrenergic Receptor Interactions with PDZ Scaffold Proteins
|Journal of Biological Chemistry|2005|134
YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression
|Journal of Experimental & Clinical Cancer Research|2020|106
The mRNA expression of SATB1 and SATB2 in human breast cancer
|Cancer Cell International|2009|103